Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ellis

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Breast Cancer Research and Treatment|May 5, 2024
Correction: Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation studyR Charles Coombes, Christina Angelou, Zamzam Al-Khalili, et al.
Breast Cancer Research and Treatment|January 20, 2024
Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation studyR Charles Coombes, Christina Angelou, Zamzam Al-Khalili, et al.
American Journal of Clinical Pathology|September 19, 2009
Chromogenic in situ hybridization: a multicenter study comparing silver in situ hybridization with FISHJ M S Bartlett, Fiona M Campbell, Merdol Ibrahim, et al.
Journal of Clinical Gastroenterology|March 25, 2008
Cystic fibrosis transmembrane conductance regulator ion channel function testing in recurrent acute pancreatitisIdit Segal, Yasmin Yaakov, Samuel N Adler, et al.
Breast Cancer Research and Treatment|March 22, 2015
Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancerRezvan Abduljabbar, Methaq Mueen Al-Kaabi, Ola H Negm, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2006
The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?Sunil R Lakhani, Werner Audretsch, Anne-Marie Cleton-Jensen, et al.
Lancet (London, England)|December 22, 2015
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trialJohn F Forbes, Ivana Sestak, Anthony Howell, et al.
Histopathology|May 8, 2024
Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR)Ian Ellis, Fleur Webster, Kimberly H Allison, et al.
Oncogene|May 18, 2005
A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenesMaria J Garcia, Jessica C M Pole, Suet-Feung Chin, et al.
Molecular Genetics and Metabolism Reports|December 6, 2023
Long-term outcomes in two adult siblings with Fucosidosis - Diagnostic odyssey and clinical manifestationsNuria Puente-Ruiz, Ian Ellis, Marsel Bregu, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Breast Cancer Research and Treatment|May 5, 2024
Correction: Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation studyR Charles Coombes, Christina Angelou, Zamzam Al-Khalili, et al.
Breast Cancer Research and Treatment|January 20, 2024
Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation studyR Charles Coombes, Christina Angelou, Zamzam Al-Khalili, et al.
American Journal of Clinical Pathology|September 19, 2009
Chromogenic in situ hybridization: a multicenter study comparing silver in situ hybridization with FISHJ M S Bartlett, Fiona M Campbell, Merdol Ibrahim, et al.
Journal of Clinical Gastroenterology|March 25, 2008
Cystic fibrosis transmembrane conductance regulator ion channel function testing in recurrent acute pancreatitisIdit Segal, Yasmin Yaakov, Samuel N Adler, et al.
Breast Cancer Research and Treatment|March 22, 2015
Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancerRezvan Abduljabbar, Methaq Mueen Al-Kaabi, Ola H Negm, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2006
The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?Sunil R Lakhani, Werner Audretsch, Anne-Marie Cleton-Jensen, et al.
Lancet (London, England)|December 22, 2015
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trialJohn F Forbes, Ivana Sestak, Anthony Howell, et al.
Histopathology|May 8, 2024
Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR)Ian Ellis, Fleur Webster, Kimberly H Allison, et al.
Oncogene|May 18, 2005
A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenesMaria J Garcia, Jessica C M Pole, Suet-Feung Chin, et al.
Molecular Genetics and Metabolism Reports|December 6, 2023
Long-term outcomes in two adult siblings with Fucosidosis - Diagnostic odyssey and clinical manifestationsNuria Puente-Ruiz, Ian Ellis, Marsel Bregu, et al.
Pageof 10